Novavax s Vaccine Will Be Produced In Canada. What Do We Know About It?
Trials are ongoing, which allow a window into how well Novavax s vaccine stands up to emerging variants of COVID-19. Patricia Treble, Maclean s Updated
February 5, 2021
Dr. Sonia Macieiewski (R) and Dr. Nita Patel, Director of Antibody discovery and Vaccine development, look at a sample of a respiratory virus at Novavax labs in Gaithersburg, Maryland on March 20, 2020, for the coronavirus, COVID-19. (Photo by ANDREW CABALLERO-REYNOLDS/AFP via Getty Images)
On Feb. 2, Prime Minister Justin Trudeau announced that Canada will start producing COVID-19 vaccines. “We’ve signed a memorandum of understanding with Novavax to produce their COVID-19 vaccine at the new NRC [National Research Council] Royalmount facility in Montreal,” the PM said. “Pending Health Canada approval, tens of millions of Novavax COVID-19 doses will be made right here at home.”